Neurology Market Research Reports & Industry Analysis

The notion “neurology” refers to a branch of medical scientific study dealing with central, peripheral and autonomic nervous systems, and their structure, functions and disorders, in particular. Companies involved in the neurology market produce a wide range of neurology devices. Neurology devices represent the largest and the most promising segments of the medical devices market.

In late 2016, the worldwide neurology devices market is expected to be over USD 7 billion. The largest neurology devices market is the USA, followed by Japan. Boston Scientific Corporation, DePuy Inc., CareFusion Corporation, Accuracy Inc. are amid major industry participants.

Research reports available in the Catalogue include data on the neurology devices market. The reports provide the profiles of the key vendors in the market space; analyses of trends factors affecting the market and forces contributing to the industry growth. The research studies evaluate the competitive landscape and future industry projections.

Found 51 publications
PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis US$ 10,995.00

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis Summary Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The ... . Additional unmet needs still exists in terms of safety and efficacy. Will the drugs under development fulfil the unmet needs of the ...

Jan, 2013 271 pages
Japanese Marktet for Neurovascular Devices US$ 6,995.00

... at nearly $553 million. The Japanese market for neurological devices includes bare platinum coils, coated coils, liquid embolics, neurovascular stents, ... in this market will be driven by the rapidly growing aging population in Japan and the increased demand and acceptance of endovascular cerebral aneurysm ...

Nov, 2013 76 pages
Chinese Market for Neurological Devices US$ 6,995.00

... was valued at over $528 million. The Chinese market for neurological devices includes fixed pressure CSF shunts, adjustable pressure CSF ... -based stereotactic systems, frameless stereotactic systems and aneurysm clips. Market growth will be driven by the continued acceptance of aneurysm treatment procedures, ...

Nov, 2013 242 pages
EpiCast Report: Acute Ischemic Stroke - Epidemiology Forecast to 2022 US$ 3,995.00

... other than that of vascular origin.” This definition excludes cases of transient ischemic attacks (TIAs), which are neurological deficits lasting less than ... entire healthcare system in each country. Scope The Acute Ischemic Stroke (AIS) EpiCast Report provides an overview of the risk factors, comorbidities ...

Sep, 2013 86 pages
Physician Views: Sanofi secures EU approval for its multiple sclerosis treatment Lemtrada – how will neurologists use it? US$ 645.00

With Sanofi securing European approval for its multiple sclerosis therapy Lemtrada last week, neurologists in the region have at their disposal a new option ... to limit the chance of patients using the drug developing PML. This week's Physician Views poll will ask neurologists based in the 5EU (France, Germany, ...

Sep, 2013
Physician Views – Which multiple sclerosis players do the best marketing job? – FirstWord polls neurologists in the US and 5EU US$ 645.00

... (known collectively as the ABCRs), which for many years were positioned as the gold standard therapies of choice - see Physician Views Poll Results – ... do their best to rectify. Analysts at Barclays recently noted that 'importantly, the multiple sclerosis market has become more dynamic since the launch of ...

Sep, 2013
The Top 50 Neurodevice Companies Worldwide US$ 464.00

... , Number of Employees, Turnover and Foreign Trade. Report Target Market: 1) Neurodevice Companies Usage: competitive/financial analysis and strategic partner/alliance ... your business. Learn more about your target markets and target companies Top level research on all the major players in a market See ...

May, 2012 97 pages
The Top 30 Neurology Contract Research Organisations In Western Europe US$ 280.00

... 's Disease and Multiple Sclerosis. They are located right across Europe, from Belgium and the Netherlands to Sweden and Denmark. Profile ... , Biotechnology and Medical Device Associations The Top 30 Neurology Contract Research Organisations In Western Europe is a useful reference tool for CRO, pharmaceutical, ...

Aug, 2013 91 pages
Global Neurovascular Market: Trends & Opportunities (2013-18) US$ 800.00

... (Ev3) and Johnson & Johnson (Micrus). The report titled “Global Neurovascular Market: Trends & Opportunities (2013-18)” provides a detailed insight into the ... sphere. The report primarily focuses on the two chief segments of neurovascular disorder: hemorrhagic stroke and ischemic stroke. The report further ...

Jul, 2013 46 pages
Indian Neurological Devices Market US$ 5,995.00

In 2012, the Indian market for neurological devices was valued at $13.5 million. The Indian market for neurological devices includes detachable coils, liquid embolics, neurovascular stents, neurovascular catheters, neurovascular guidewires, neuromodulation systems, neuroendoscopes, stereotactic systems and ...

Aug, 2013 236 pages
Neurostimulation Devices Market, 2012-2017 US$ 1,699.00

... continue to be the largest segment in the neurostimulation devices market over the forecast period (2012 to 2017). 3. Deep Brain Stimulation (DBS) segment ... companies. It also contains a SWOT analysis and detailed profile of leading devices within this segment. We have looked at both the existing commercial ...

Nov, 2012 124 pages
Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H1 2014 US$ 2,000.00

... (Cushing's Disease) - Pipeline Review, H1 2014’, provides an overview of the Pituitary ACTH Hypersecretion (Cushing's Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pituitary ACTH Hypersecretion (Cushing's Disease), complete with ...

Apr, 2014 72 pages
Neuropathy – Pipeline Review, H1 2013 US$ 2,000.00

... key players involved in the therapeutic development for Neuropathy. Neuropathy - Pipeline Review, Half Year is built using data and information sourced ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons ...

Apr, 2013 77 pages
Essential Tremor – Pipeline Review, H1 2013 US$ 2,000.00

... reviews key players involved in the therapeutic development for Essential Tremor. Essential Tremor - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons ...

Apr, 2013 32 pages
Global Deep Brain Stimulator Market 2012-2016 US$ 2,000.00 US$ 1,800.00

... the Americas, and the EMEA and APAC regions; it covers the Global Deep Brain Stimulator market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space are Boston Scientific Corp., ...

Apr, 2013 37 pages
Global Neurostimulation Devices Market 2012-2016 US$ 2,500.00 US$ 2,250.00

... could pose a challenge to the growth of this market. TechNavio's report, Global Neurostimulation Devices Market 2012-2016, has been prepared based on an in-depth ... . The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space are Medtronic Inc., ...

Apr, 2013 37 pages
Intraoperative Neuromonitoring Market in the US 2015-2019 US$ 2,500.00

... the electrical activity in the brain. TechNavio's analysts forecast the Intraoperative Neuromonitoring market in the US to grow at a CAGR of 8.19 percent over the period 2015- ... our report Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What ...

Nov, 2014 89 pages
European Neurological Device Markets US$ 8,995.00

In 2011, the total European market for neurological devices was valued at €628.3 million. Market growth will be driven by the continued acceptance of ... hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that ...

Mar, 2013 410 pages
PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022'. ... have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have significant ...

Feb, 2013 136 pages
PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022'. ... have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have significant ...

Feb, 2013 135 pages
PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022'. ... impact of key events as well the drivers and restraints affecting Spain Epilesy market. REASONS TO BUY Understand and capitalize by identifying products ...

Feb, 2013 129 pages
PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022'. ... impact of key events as well the drivers and restraints affecting Japan Epilesy market. REASONS TO BUY Understand and capitalize by identifying products ...

Feb, 2013 135 pages
PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022'. ... impact of key events as well the drivers and restraints affecting Italy Epilesy market. REASONS TO BUY Understand and capitalize by identifying products ...

Feb, 2013 132 pages
PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022 ... , a growing middle class with better healthcare access, and increased epilepsy treatment in the whole population. However, loose government regulation of patent ...

Feb, 2013 128 pages
PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022 ... is the launch of generics and the high rate of generic substitution in Germany. In addition, strict government pricing restrictions will limit the the ...

Feb, 2013 136 pages
PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022 ... impact of key events as well the drivers and restraints affecting France Epilesy market. REASONS TO BUY Understand and capitalize by identifying products ...

Feb, 2013 130 pages
PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022'. ... general population, which drives the growth of the prevalent population of epilepsy patients, the AED market is fairly large, despite the relatively ...

Feb, 2013 114 pages
EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2022 US$ 3,995.00

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2022 SUMMARY Alzheimer’s disease is the most common cause of dementia in people age 60 years and ... for care of persons affected with the disease. SCOPE The Alzheimer’s disease EpiCast Report provides an overview of the risk factors and ...

Feb, 2013 42 pages
Global Neurovascular Intervention Devices Market 2011-2015 US$ 1,500.00 US$ 1,350.00

... huge patient population with various neurological disorders. The Global Neurovascular Intervention Devices market has also been witnessing the trend of an increase ... in the report are Gore Medical, ITGI Medical Ltd., Neuro Interventional Therapeutics Inc., and Medtronic Inc. Key questions answered in this ...

Nov, 2012 44 pages
Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, & Cerebral Angioplasty Balloons] – Global Trends &... US$ 4,650.00

... market including India, China and Japan, and Latin America market are expected to grow at a higher pace due to the effect of growing GDP ... the neurointerventional device market for devices used in neurothrombectomy procedure, cerebral angiography and stenting technique, aneurysm coiling procedure and support ...

Oct, 2012 234 pages
Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2014 US$ 2,000.00

... (Cushing's Disease) - Pipeline Review, H2 2014’, provides an overview of the Pituitary ACTH Hypersecretion (Cushing's Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pituitary ACTH Hypersecretion (Cushing's Disease), complete with ...

Oct, 2014 73 pages
Neuropathy - Pipeline Review, H2 2013 US$ 2,000.00

... and discontinued projects. It also reviews key players involved in the therapeutic development for Neuropathy. Neuropathy - Pipeline Review, Half Year is built ... news and deals relating to the products. Reasons to buy Identify and understand important and diverse types of therapeutics under development for ...

Oct, 2013 36 pages
Essential Tremor – Pipeline Review, H2 2012 US$ 2,000.00

... reviews key players involved in the therapeutic development for Essential Tremor. Essential Tremor - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. REASONS ...

Oct, 2012 37 pages
Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth US$ 3,500.00

... for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth Summary GBI Research’s report, “Neurology Devices Market to 2017 - High Potential ... market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010 has been given for ...

Jul, 2011 118 pages
United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

... Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub- ... Design competition strategies by identifying who-stands-where in the United Arab Emirates Neurology Devices competitive landscape. Develop capital investment strategies by identifying ...

May, 2012 109 pages
Turkey Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

... Opportunities, Analysis and Forecasts to 2018 Summary ”Turkey Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Turkey Neurology Devices market. The report provides value (USD million), volume ( ...

May, 2012 106 pages
Switzerland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

... , Analysis and Forecasts to 2018 Summary ”Switzerland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, ... Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub ...

May, 2012 108 pages
Portugal Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

... Opportunities, Analysis and Forecasts to 2018 Summary ”Portugal Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Portugal Neurology Devices market. The report provides value (USD million), volume ( ...

May, 2012 99 pages
Poland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

... Opportunities, Analysis and Forecasts to 2018 Summary ”Poland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Poland Neurology Devices market. The report provides value (USD million), volume ( ...

May, 2012 105 pages
Norway Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

... Opportunities, Analysis and Forecasts to 2018 Summary ”Norway Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Norway Neurology Devices market. The report provides value (USD million), volume ( ...

May, 2012 96 pages
Ireland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

... Opportunities, Analysis and Forecasts to 2018 Summary ”Ireland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Ireland Neurology Devices market. The report provides value (USD million), volume ( ...

May, 2012 99 pages
Hungary Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

... Opportunities, Analysis and Forecasts to 2018 Summary ”Hungary Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Hungary Neurology Devices market. The report provides value (USD million), volume ( ...

May, 2012 98 pages
Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

... Opportunities, Analysis and Forecasts to 2018 Summary ”Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Greece Neurology Devices market. The report provides value (USD million), volume ( ...

May, 2012 103 pages
Finland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

... Opportunities, Analysis and Forecasts to 2018 Summary ”Finland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Finland Neurology Devices market. The report provides value (USD million), volume ( ...

May, 2012 98 pages
Egypt Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

... Opportunities, Analysis and Forecasts to 2018 Summary ”Egypt Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Egypt Neurology Devices market. The report provides value (USD million), volume (units ...

May, 2012 98 pages
Chile Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

... Opportunities, Analysis and Forecasts to 2018 Summary ”Chile Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Chile Neurology Devices market. The report provides value (USD million), volume (units ...

May, 2012 105 pages
European Markets for Neurological Devices 2010 (15 Countries) US$ 11,495.00

... devices. This market includes: Cerebrospinal fluid (CSF) shunts CSF drainage systems Detachable coils Liquid embolics Neurovascular catheters Neurovascular guidewires Neurovascular stents Spinal cord stimulators Vagus nerve stimulators Deep brain stimulators Sacral nerve stimulators ...

Jun, 2010 369 pages
European Markets for Neurological Devices 2010 (15 Countries) (Executive Summary) US$ 195.00

In 2009, the European market for neurological devices was valued at almost €500 million. This report covers Austria, Benelux, France, Germany, Italy, ... as Boston Scientific, Carl Zeiss, Codman, Medtronic and St. Jude lead the market, among many others. This report provides a comprehensive and detailed analysis ...

Jun, 2010 12 pages
U.S. Market for Neurological Devices US$ 5,995.00

In 2011, the U.S. neurological device market was valued at over $2.7 billion. This market encompasses CSF shunts, CSF external drainage systems, intracranial pressure ... and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The ...

Mar, 2013 396 pages
The Future of the Neurology Devices Market to 2016 – Market Forecasts, Competitive Landscape and Pipeline Analysis US$ 3,500.00

The Future of the Neurology Devices Market to 2016 – Market Forecasts, Competitive Landscape and Pipeline Analysis

Summary

GBI Research’s report, “The Future of the Neurology Devices Market to 2016...

Feb, 2010 74 pages
1 2 >
Skip to top